Hepatitis C OnlineLogo
Section Navigation
Common TitleENDURANCE-2
Official Title Efficacy of Glecaprevir/Pibrentasvir for 12 Weeks in Patients with HCV Genotype 2, 4, 5, or 6 Infection Without Cirrhosis.
Phase Phase III
ClinicalTrials.gov NCT02640482
Treatments
Glecaprevir-Pibrentasvir

Glecaprevir-Pibrentasvir

Tradename:MavyretOther Names:GLE-PIBClass:FDA-Approved
Funding
IndustryAbbVie
Open Slide Deck

Share by e-mail

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.